WE ARE PASSIONATE ABOUT SUPPORTING PARENTS

“UK Euroscepticism and the Brexit Referendum.” Political Quarterly 87(2): 219–27. “Fear, Anger and Enthusiasm about the European Union: Effects of Emotional Reactions on Public Preferences towards European Integration.” European Union Politics 18(3): 382–405. “The Generalizability of Personality Effects in Politics.” European Journal of Personality 33(6): 631–41.

• [History: Founded in 2015 by local residents concerned about planning corruption.]
• [First campaign successfully stopped the sale of a public park to a private developer.]
• [Grew rapidly after the 2017 anti-incinerator campaign garnered widespread support.]
• [Incorporated as a non-profit in 2019 to improve structure and funding opportunities.]
• [Expanded focus from purely environmental issues to broader social justice concerns.]
• [Survived the pandemic by shifting to online organizing and virtual events.]
• [Notable for a member serving on the town council after a 2022 election campaign.]
• [Received regional award for community impact and innovation in activism in 2024.]
• [Currently managing twice as many active campaigns as in its first five years.]
• [Plans to develop a youth wing to ensure long-term sustainability and fresh ideas.]

“Electoral Competitiveness and Turnout in British Elections, 1964–2010.” Political Science Research and Methods: 1–20. “Brexit’s Impact on the Political System of the United Kingdom.” In Research Handbook on Legal Aspects of Brexit, Cheltenham: Elgar, 17–32. “Fear and Anger in Great Britain: Blame Assignment and Emotional Reactions to the Financial Crisis.” Political Behavior 36(3): 683–703. “Fighting With Fire: Negative Campaigning in the 2015 UK General Election Campaign as Reported by the Print Media.” In The Psychology of Political Communicators, eds. “Measures of Campaign Negativity: Comparing Approaches and Eliminating Partisan Bias.” The International Journal of Press/Politics 24(3): 363–82.

The Efficiency through Technology Programme

“Explaining Reactions to Inflation: Early-Life Experiences and Mass Preferences for Price Increases.” (4686442). “UKIP Support in Local Elections: Which Factors Play a Role in Determining Electoral Fortunes?” British Politics 18(4): 623–46. “The Electoral Effects of the Descriptive Representation of Ethnic Minority Groups in Australia and the UK.” Party Politics 22(6): 691–704. “Turnout Turnaround: Ethnic Minority Victories Mobilize White Voters.” American Political Science Review. The NOMAN is an Island: Race to End HPV Campaign is joining forces with Jo’s Cervical Cancer Trust to launch and co-chair a new HPV Coalition.

Dr Andrew N Holding

The HPV Coalition, established in 2022, is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards elimination of HPV-related cancers – cancers which account for 5% of all cancers globally, and which we now, for the first time in history, have the opportunity to eliminate as a public health threat. Despite the scale of the opportunity, the UK has yet to take the step of other countries, such as Australia and Canada, in developing an action plan for cervical cancer elimination. The UK also lags behind the European Union which, through the Beating Cancer Plan, has gone one step further, in committing to eliminate all HPV cancers. The HPV Coalition is therefore eager to see the UK put in place a concrete plan for elimination as a matter of priority, targeted at the whole range of HPV-related cancers and supporting access to preventative interventions for all parts of the population. The Coalition will stand at the forefront of UK policymaking and will bring together a membership of patient organisations, professional groups, clinicians, and expert individuals to build and demonstrate broad stakeholder consensus around the significant – and as yet unharnessed – opportunity to pursue eliminationin the UK.

Dr Tim Harrison

The membership will advocate for commitment and action from all UK governments to pursue elimination of the whole range of HPV-related cancers, in both men and women. As a first step on this journey, the HPV Coalition will develop a UK elimination roadmap, clearly setting out the steps required to achieve elimination of HPV-related cancers, including the areas where further research is required. On October 24th 2022, the Coalition was officially launched in the Palace of Westminster in an event hosted by long standing HPV advocate, Jess Phillips MP. The HPV Coalition is proud to cenforce professional 100 publish the next step in that journey, our Roadmap towards making the elimination of all HPV-related cancers a reality across the UK, which you can read below. The Roadmap serves as our call to Governments across the four nations of the UK to take action, while providing the blueprint of how elimination can be delivered. “Unintended Consequences of Negative Campaigning: Backlash and Second-Preference Boost Effects in a Multi-Party Context.” British Journal of Politics and International Relations 21(3):612–29. “Political Trust, Civic Duty and libido booster women Voter Turnout: The Mediation Argument.” Social Science Journal 53(3): 291–300. Party Switching among Grassroots Members in Britain.” Journal of Elections, Public Opinion and Parties 33(2): 247–57.

Product	Dosage	Quantity + Bonus	Price
Levitra Soft Tabs	20mg	10 Pills	52.27€ 49.78€	Buy
Cialis Generic	2.5mg	180 + 10 Pills	154.86€ 147.49€	Buy
Kamagra Oral Jelly	100mg	10 Sachets	54.55€ 51.95€	Buy
Viagra Professional	100mg	360 + 6 Pills	527.09€ 501.99€	Buy
Kamagra Gold	50 mg	360 + 6 Pills	713.95€ 679.95€	Buy
Viagra Generic	100mg	10 Pills	28.91€ 27.53€	Buy
Kamagra Gold	100 mg	360 + 6 Pills	839.95€ 799.95€	Buy
Cialis Generic	10mg	360 + 10 Pills	388.49€ 369.99€	Buy
Viagra Professional	100mg	20 Pills	71.14€ 67.75€	Buy
Levitra Soft Tabs	20mg	90 + 6 Pills	241.31€ 229.82€	Buy
Cialis Super Active	20mg	180 + 20 Pills	521.59€ 496.75€	Buy
Kamagra Soft Tabs	100 mg	20 Pills	79.79€ 75.99€	Buy
Cialis Generic	5mg	30 + 4 Pills	53.56€ 51.01€	Buy
Viagra Generic	150mg	270 + 10 Pills	326.61€ 311.06€	Buy

“‘All Mouth and No Trousers?’ How Many Conservative Party Members Voted for UKIP in 2015 – and Why Did They Do So?” Politics 37(4): 432–44. “So Who Really Does the Donkey Work in ‘Multi-Speed Membership Parties’? Comparing the Election Campaign Activity of Party Members and Party Supporters.” Electoral Studies 46: 64–74.

Content Type	Quantity	Last Update	Purpose
Blog Posts	45	Weekly	Educate and engage visitors
Campaign Videos	15	Monthly	Visual storytelling
Newsletters	20	Bi-weekly	Updates and calls to action
Infographics	8	Quarterly	Simplify data & advocacy messages

“Beginnings of the Russo-Ukrainian War.” In Russia’s Invasion of Ukraine: Economic Challenges, Embargo Issues and a New Global Economic Order, ed. “How the Polls Have Changed since 2015.” UK Polling Report. West, Brady T, and Rebecca R Andridge. “Evaluating Pre-Election Polling Estimates Using a New Measure of Non-Ignorable Selection Bias.” Public Opinion Quarterly 87(S1): 575–601. “Has Age Replaced Class in British Elections? A Hierarchical Age-Period-Cohort Analysis.” Electoral Studies 86. doi:10.1016/j.electstud.2023.102695. Why Did Labour Party Membership Soar after the 2015 General Election?” The British Journal of Politics and International Relations 21(1): 80–98. “What Kind of Party Is the UK Independence Party? The Future of the Extreme Right in Britain or Just Another Tory Party?” Political Studies 66(3): 577–600. “White, Male, and Angry: A Reputation-Based Rationale.” SSRN Electronic Journal. “How Do Economic Crises Affect Electoral Choices? Analyzing Voting Behavior in the British General Election of 2010.” In Economic Crises and Policy Regimes: The Dynamics of Policy Innovation and Paradigmatic Change, ed. Using Home Movers to Identify Local Campaign Effects. “Partisanship, Attribution and Approval in a vardenafil premature ejaculation Public Health Shock.” Electoral Studies 84. doi:10.1016/j.electstud.2023.102643. “Explaining Reactions to Inflation: Early-Life Experiences and Mass Preferences for Price Increases.” (4686442). “UKIP Support in Local Elections: Which Factors Play a Role in Determining Electoral Fortunes?” British Politics 18(4): 623–46.

• [Contact: Email info@ceridaviescampaigner.co.uk for general inquiries and support.]
• [Phone: Leave a message on the campaign hotline for urgent matters or to volunteer.]
• [Address: Send postal mail to the community center, marked for the campaign group.]
• [Meeting: Attend the drop-in session every Tuesday afternoon at the library annex.]
• [Councillor liaison: Direct contact details for sympathetic local representatives provided.]
• [Press: Media inquiries should be directed to the press officer via the main email.]
• [Legal: For formal complaints or legal issues, contact the dedicated advice line.]
• [Partnerships: Organizations seeking collaboration can email partnerships address.]
• [Volunteering: Specific email for volunteering opportunities and role applications.]
• [Feedback: Use the online form on the website to suggest ideas or report problems.]

“The Electoral Effects of the Descriptive Representation of Ethnic Minority Groups in Australia and the UK.” Party Politics 22(6): 691–704. “Turnout Turnaround: Ethnic Minority Victories Mobilize White Voters.” American Political Science Review.

Telstra ‘Synthesiser’ (+61 with Bear Meets Eagle On Fire)

The NOMAN is an Island: Race to End HPV Campaign is joining forces with Jo’s Cervical Cancer Trust to launch and co-chair a new HPV Coalition. The HPV Coalition, established in 2022, is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards elimination of HPV-related cancers – cancers which account for 5% of all cancers globally, and which we now, for the first time in history, have the opportunity to eliminate as a public health threat. Despite the scale of the opportunity, the UK has yet to take the step of other countries, such as Australia and Canada, in developing an action plan for cervical cancer elimination.

Academi Wales Business Plan 2021 to 2022

Our goal is simple Make the elimination of all HPV-related cancers a reality across the UK. We have many of the tools available to us now to make this a reality, and we must ensure it is grasped without delay. To achieve this, we must ensure foundations of HPV prevention are strengthened across the UK. Our Roadmap is therefore made up of a number of building blocks – with associated actions – that plot our course to elimination: Improving education on HPV to tackle stigma and drive access to prevention Making sure everyone has equitable access to screening and early diagnosis Restoring and boosting immunisation uptake, including catch-up programmes Enhancing the data, digital and workforce infrastructure It is critical that UK governments set out a concrete strategy for the elimination of all HPV-related cancers, widening the scope of our ambition beyond cervical cancer elimination. Along with our fellow members of the HPV Coalition, we stand ready to support the implementation of recommendations and take meaningful steps to prevent HPV-related cancers from affecting the lives of so many women and men.

Danielle Nicholson

We recognise that concerted and collaborative action is essential to success, and therefore the HPV Coalition is committed to working in close and positive partnership with parliamentarians and policymakers in support of elimination ambitions, ensuring that the UK’s current opportunity to lead the world in HPV elimination is not missed. For further information on HPV Coalition activity please contact the secretariat – provided by Incisive Health – at HPVCoalition@incisivehealth.com. Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Nigel Carter, Chief Executive, Oral Health Foundation Dr Nigel Carter, Chief Executive, Oral Health Foundation Professor Emma Crosbie, Professor of Gynaecological Oncology Professor Emma Crosbie, Professor of Gynaecological Oncology Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Helen Donovan, Immunisation and Vaccination Specialist Nurse Helen Donovan, Immunisation and Vaccination Specialist Nurse Anita Harris, Director of Clinical Operations, Brook Anita Harris, Director of Clinical Operations, Brook Melvyn Hill, Chief Executive, UK Cervical Cancer Melvyn Hill, Chief Executive, UK Cervical Cancer Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Vas James, Head of Programmes, The Eve Appeal Vas James, Head of Programmes, The Eve Appeal Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Tamara Kahn, Chief Executive, Oracle Cancer Trust Tamara Kahn, Chief Executive, Oracle Cancer Trust Athena Lamnisos, Chief Executive, The Eve Appeal Athena Lamnisos, Chief Executive, The Eve Appeal Hilary Maxwell, CEO and Chair, GO Girls Hilary Maxwell, CEO and Chair, GO Girls Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Dr Sue Sherman, Reader in Psychology, Keele University Dr Sue Sherman, Reader in Psychology, Keele University Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Martin Tod, Chief Executive, Men’s Health Forum Martin Tod, Chief Executive, Men’s Health Forum Professor Martin Widschwendter, Professor in Women's Cancer, University College London Professor Martin Widschwendter, Professor in Women's Cancer, University College London Support for the HPV Coalition is provided by BD UK Ltd, Hologic UK Ltd, MSD UK Ltd, and Roche Diagnostics UK Ltd , who fund HPV Coalition meetings, activities, and the HPV Coalition secretariat, delivered by Incisive Health.

Caroline Harding

The UK also lags behind the European Union which, through the Beating Cancer Plan, has gone one step further, in committing to eliminate all HPV cancers.

Recruitment of three critical vacancies for Employability and Skills

“UK Euroscepticism and the Brexit Referendum.” Political Quarterly 87(2): 219–27. “Fear, Anger and Enthusiasm about the European Union: Effects of Emotional Reactions on Public Preferences towards European Integration.” European Union Politics 18(3): 382–405. “The Generalizability of Personality Effects in Politics.” European Journal of Personality 33(6): 631–41. “Electoral Competitiveness and Turnout in British Elections, 1964–2010.” Political Science Research and Methods: 1–20. “Brexit’s Impact on the Political System of the United Kingdom.” In Research Handbook on Legal Aspects of Brexit, Cheltenham: Elgar, 17–32.

Sam Guglani

“Fear and Anger in Great Britain: Blame Assignment and Emotional Reactions to the Financial Crisis.” Political Behavior 36(3): 683–703. “Fighting With Fire: Negative Campaigning in the 2015 UK General Election Campaign as Reported by the Print Media.” In The Psychology of Political Communicators, eds. “Measures of Campaign Negativity: Comparing Approaches and Eliminating Partisan Bias.” The International Journal of Press/Politics 24(3): 363–82. “Unintended Consequences of Negative Campaigning: Backlash and Second-Preference Boost Effects in a Multi-Party Context.” British Journal of Politics and International Relations 21(3):612–29. “Political Trust, Civic Duty and libido booster women Voter Turnout: The Mediation Argument.” Social Science Journal 53(3): 291–300.

What would you change about Cardiff and why?

Party Switching among Grassroots Members in Britain.” Journal of Elections, Public Opinion and Parties 33(2): 247–57. “‘All Mouth and No Trousers?’ How Many Conservative Party Members Voted for UKIP in 2015 – and Why Did They Do So?” Politics 37(4): 432–44. “So Who Really Does the Donkey Work in ‘Multi-Speed Membership Parties’? Comparing the Election Campaign Activity of Party Members and Party Supporters.” Electoral Studies 46: 64–74. “Beginnings of the Russo-Ukrainian War.” In Russia’s Invasion of Ukraine: Economic Challenges, Embargo Issues and a New Global Economic Order, ed. The HPV Coalition is therefore eager to see the UK put in place a concrete plan for elimination as a matter of priority, targeted at the whole range of HPV-related cancers and supporting access to preventative interventions for all parts of the population. The Coalition will stand at the forefront of UK policymaking and will bring together a membership of patient organisations, professional groups, clinicians, and expert individuals to build and demonstrate broad stakeholder consensus around the significant – and as yet unharnessed – opportunity to pursue eliminationin the UK. The membership will advocate for commitment and action from all UK governments to pursue elimination of the whole range of HPV-related cancers, in both men and women. As a first step on this journey, the HPV Coalition will develop a UK elimination roadmap, clearly setting out the steps required to achieve elimination of HPV-related cancers, including the areas where further research is required. On October 24th 2022, the Coalition was officially launched in the Palace of Westminster in an event hosted by long standing HPV advocate, Jess Phillips MP. The HPV Coalition is proud to cenforce professional 100 publish the next step in that journey, our Roadmap towards making the elimination of all HPV-related cancers a reality across the UK, which you can read below. The Roadmap serves as our call to Governments across the four nations of the UK to take action, while providing the blueprint of how elimination can be delivered. Our goal is simple Make the elimination of all HPV-related cancers a reality across the UK. We have many of the tools available to us now to make this a reality, and we must ensure it is grasped without delay. To achieve this, we must ensure foundations of HPV prevention are strengthened across the UK. Our Roadmap is therefore made up of a number of building blocks – with associated actions – that plot our course to elimination: Improving education on HPV to tackle stigma and drive access to prevention Making sure everyone has equitable access to screening and early diagnosis Restoring and boosting immunisation uptake, including catch-up programmes Enhancing the data, digital and workforce infrastructure It is critical that UK governments set out a concrete strategy for the elimination of all HPV-related cancers, widening the scope of our ambition beyond cervical cancer elimination. Along with our fellow members of the HPV Coalition, we stand ready to support the implementation of recommendations and take meaningful steps to prevent HPV-related cancers from affecting the lives of so many women and men.

Food Standards Agency Wales funding

“How the Polls Have Changed since 2015.” UK Polling Report. West, Brady T, and Rebecca R Andridge. “Evaluating Pre-Election Polling Estimates Using a New Measure of Non-Ignorable Selection Bias.” Public Opinion Quarterly 87(S1): 575–601. “Has Age Replaced Class in British Elections? A Hierarchical Age-Period-Cohort Analysis.” Electoral Studies 86.

Betsy Lewis-Holmes

doi:10.1016/j.electstud.2023.102695. Why Did Labour Party Membership Soar after the 2015 General Election?” The British Journal of Politics and International Relations 21(1): 80–98. “What Kind of Party Is the UK Independence Party? The Future of the Extreme Right in Britain or Just Another Tory Party?” Political Studies 66(3): 577–600. “White, Male, and Angry: A Reputation-Based Rationale.” SSRN Electronic Journal.

Nicola Gibson

“How Do Economic Crises Affect Electoral Choices? Analyzing Voting Behavior in the British General Election of 2010.” In Economic Crises and Policy Regimes: The Dynamics of Policy Innovation and Paradigmatic Change, ed. Using Home Movers to Identify Local Campaign Effects. “Partisanship, Attribution and Approval in a vardenafil premature ejaculation Public Health Shock.” Electoral Studies 84. doi:10.1016/j.electstud.2023.102643. We recognise that concerted and collaborative action is essential to success, and therefore the HPV Coalition is committed to working in close and positive partnership with parliamentarians and policymakers in support of elimination ambitions, ensuring that the UK’s current opportunity to lead the world in HPV elimination is not missed. For further information on HPV Coalition activity please contact the secretariat – provided by Incisive Health – at HPVCoalition@incisivehealth.com. Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV Dr Nigel Carter, Chief Executive, Oral Health Foundation Dr Nigel Carter, Chief Executive, Oral Health Foundation Professor Emma Crosbie, Professor of Gynaecological Oncology Professor Emma Crosbie, Professor of Gynaecological Oncology Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Dr Anne Connolly, Chair, Primary Care Women’s Health Forum Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester Helen Donovan, Immunisation and Vaccination Specialist Nurse Helen Donovan, Immunisation and Vaccination Specialist Nurse Anita Harris, Director of Clinical Operations, Brook Anita Harris, Director of Clinical Operations, Brook Melvyn Hill, Chief Executive, UK Cervical Cancer Melvyn Hill, Chief Executive, UK Cervical Cancer Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Catrin Hughes, Faculty of Sexual and Reproductive Healthcare Vas James, Head of Programmes, The Eve Appeal Vas James, Head of Programmes, The Eve Appeal Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Lorna Kelly, Faculty of Sexual and Reproductive Healthcare Tamara Kahn, Chief Executive, Oracle Cancer Trust Tamara Kahn, Chief Executive, Oracle Cancer Trust Athena Lamnisos, Chief Executive, The Eve Appeal Athena Lamnisos, Chief Executive, The Eve Appeal Hilary Maxwell, CEO and Chair, GO Girls Hilary Maxwell, CEO and Chair, GO Girls Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London Dr Sue Sherman, Reader in Psychology, Keele University Dr Sue Sherman, Reader in Psychology, Keele University Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust Martin Tod, Chief Executive, Men’s Health Forum Martin Tod, Chief Executive, Men’s Health Forum Professor Martin Widschwendter, Professor in Women's Cancer, University College London Professor Martin Widschwendter, Professor in Women's Cancer, University College London Support for the HPV Coalition is provided by BD UK Ltd, Hologic UK Ltd, MSD UK Ltd, and Roche Diagnostics UK Ltd , who fund HPV Coalition meetings, activities, and the HPV Coalition secretariat, delivered by Incisive Health.